Sec Form 3 Filing - F2 MG Ltd @ Allovir, Inc. - 2022-07-28

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person F2 MG Ltd 2. Issuer Name and Ticker or Trading Symbol Allovir, Inc. [ ALVR] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O LJ FIDUCIARY, 8, RUE SAINT-LEGER, 3. Date of Earliest Transaction (MM/DD/YY) 07/28/2022 (Street) GENEVA, V8CH-1205 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 2,059,884 D( 1 ) Common Stock 668,072 I( 2 ) By F2-TPO Investments, LLC Common Stock 2,038,583 I( 3 ) By F2 MC, LLC Common Stock 4,193,874 I( 4 ) By F2 Capital I 2020 LLC Common Stock 867,678 I( 5 ) By F2 Bioscience AV 2022 LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other F2 MG Ltd C/O LJ FIDUCIARY, 8, RUE SAINT-LEGER GENEVA, V8CH-1205 X X Globeways Holdings Ltd C/O LJ FIDUCIARY, 8, RUE SAINT-LEGER GENEVA, V8CH-1205 X X F2 - TPO Investments LLC C/O SINGER MCKEON, 8 WEST 38TH STREET, SUITE 1001 NEW YORK, NY10018 X X F2 MC, LLC C/O SINGER MCKEON, 8 WEST 38TH STREET, SUITE 1001 NEW YORK, NY10018 X X F2 Capital I 2020 C/O SINGER MCKEON, 8 WEST 38TH STREET, SUITE 1001 NEW YORK, NY10018 X X F2 Bioscience AV 2022 LLC C/O SINGER MCKEON, 8 WEST 38TH STREET, SUITE 1001 NEW YORK, NY10018 X X Globeways Holdings II Ltd C/O SINGER MCKEON, 8 WEST 38TH STREET, SUITE 1001 NEW YORK, NY10018 X X Signatures F2 MG LTD., By: Globeways Holdings Ltd., Its: Manager, By: /s/ Morana Jovan-Embiricos, Director 08/05/2022 Signature of Reporting Person Date F2-TPO INVESTMENTS, LLC, By: /s/ Morana Jovan-Embiricos, Director 08/05/2022 Signature of Reporting Person Date F2 MC, LLC, By: /s/ Morana Jovan-Embiricos, Director 08/05/2022 Signature of Reporting Person Date F2 CAPITAL I 2020 LLC, By: /s/ Morana Jovan-Embiricos, Director 08/05/2022 Signature of Reporting Person Date F2 BIOSCIENCE AV 2022 LLC, By: /s/ Morana Jovan-Embiricos, Director 08/05/2022 Signature of Reporting Person Date GLOBEWAYS HOLDINGS LTD., By: /s/ Morana Jovan-Embiricos, Director 08/05/2022 Signature of Reporting Person Date GLOBEWAYS HOLDINGS II LTD., By: /s/ Morana Jovan-Embiricos, Director 08/05/2022 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Shares held by F2 MG Ltd. ("F2 MG"). Globeways Holdings Ltd. is the appointed manager of F2 MG and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. Morana Jovan-Embiricos is the founding director of Globeways Holdings Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. ( 2 )Shares held by F2-TPO Investments, LLC ("F2-TPO"). Globeways Holdings II Ltd. is the appointed manager of F2-TPO and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. ( 3 )Shares held by F2 MC, LLC ("F2 MC"). Globeways Holdings II Ltd. is the appointed manager of F2 MC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. ( 4 )Shares held by F2 Capital I 2020 LLC ("F2 2020"). Globeways Holdings II Ltd. is the appointed manager of F2 2020 and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 2020. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. ( 5 )Shares held by F2 Bioscience AV 2022 LLC ("F2 2022"). Globeways Holdings II Ltd. is the appointed manager of F2 2022 has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 2022. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Ltd., and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Ltd. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks: Morana Jovan-Embiricos, the founding director of each of Globeways Holdings Ltd. and Globeways Holdings II Ltd., serves on the board of directors of the Issuer. By virtue of her representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Dr. Embiricos has filed separate Section 16 reports disclosing securities of the Issuer that she may be deemed to beneficially own for Section 16 purposes. This filing shall not be deemed an admission that any Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act or otherwise, or is subject to Section 16 of the Exchange Act, and each Reporting Person disclaims beneficial ownership of these securities, except to the extent of such Reporting Person's pecuniary interest therein, if any.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements o r omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.